Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - ascorbic acid,cupric sulfate,citrus bioflavonoids extract,d-alpha-tocopherol,dunaliella salina,euphrasia officinalis,glutamine,riboflavine,tagetes erecta,taurine,vaccinium myrtillus,zinc gluconate -

United States - English - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see  warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see  warnings  and  dosage and administration ). cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery peri

United States - English - NLM (National Library of Medicine)

clinical solutions wholesale, llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride or within 14 days of stopping treatment with nortriptyline hydrochloride is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated ( see warnings and dosage and administration ). starting nortriptyline hydrochloride in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; pregelatinised maize starch; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; purified talc; disodium edetate; microcrystalline cellulose; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000; iron oxide black - amitriptyline alphapharm 50mg tablets are indicated only for the maintenance treatment of major depression. (see precautions). nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - ascorbic acid,biotin,calcium pantothenate,cyanocobalamin,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavine,thiamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - hydroxycitrate complex -

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - ascorbic acid,betacarotene,biotin,borax,calcium amino acid chelate,calcium pantothenate,cholecalciferol,choline bitartrate,chromium picolinate,citrus bioflavonoids extract,cupric sulfate anhydrous,cyanocobalamin,d-alpha-tocopheryl acid -

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - fish oil - natural -

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - ascorbic acid,biotin,calcium pantothenate,cyanocobalamin,ferrous fumarate,folic acid,nicotinamide,pyridoxine hydrochloride,riboflavin,thiamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

optimum healthcare pty ltd t/a sanofi consumer healthcare - fish oil - natural -